Skip to main content
TipRanks
Go Ultimate75% OFF

Vor Biopharma (VOR) Q2 2026 Earnings Report

959 Followers

VOR Q2 2026 EPS Results

Actual EPS
-$1.16
Consensus EPS
-$0.70
Beat/Miss
Missed by -$0.46
One Year Ago EPS
-$251.22

VOR Q2 2026 Revenue Results

Actual Revenue
$0
Expected Revenue
$0
Beat/Miss
Met expectations
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q2 2026
Date
08/11/2026
Time
Before Open
Conference Call
Tuesday, August 11, 2026
VOR Upcoming Earnings

Vor Biopharma's next earnings date is estimated for March 25, 2027, based on past reporting schedules.

Q2 2026 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2026 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2026 Earnings Call Summary

No earnings call summary is available for this earnings event.

VOR Earnings History

VOR earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 25, 20272026 (Q4)-0.99-44.5――
Oct 30, 20262026 (Q3)-1.08-1.45-121.6398.81% (+120.18)
Aug 11, 20262026 (Q2)-0.70-1.16-251.2299.54% (+250.06)
May 07, 20262026 (Q1)-0.78-5.11-5.21.73% (+0.09)
Mar 30, 20262025 (Q4)15.6844.50-8.8605.68% (+53.30)
Nov 13, 20252025 (Q3)―-121.63-8-1420.38% (-113.63)
Aug 07, 20252025 (Q2)-0.44-0.26-0.4136.59% (+0.15)
May 08, 20252025 (Q1)-0.26-0.25-0.4544.44% (+0.20)
Mar 20, 20252024 (Q4)-5.71-8.80-7.8-12.82% (-1.00)
Nov 06, 20242024 (Q3)-0.40-0.40-0.4918.37% (+0.09)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed